- US-listed companies
- 9 METERS BIOPHARMA, INC.
- Income statement
9 METERS BIOPHARMA, INC.【NMTRQ】Income statement
Market cap
$1.45K
P/E ratio
| 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | |
| Revenue | 4 | 2 | - | - | - | - | - |
| Revenue growth (%) | - | - | - | - | - | - | |
| Cost of revenue | 3 | 2 | - | - | - | - | - |
| Gross profit | 1 | -0 | - | - | - | - | - |
| Gross margin (%) | - | - | - | - | - | ||
| Research & development | 0 | 0 | 8 | 14 | - | - | - |
| Operating margin (%) | - | - | - | - | - | ||
| Operating expenses | 7 | 9 | 18 | 26 | 61 | 37 | 42 |
| Operating income | -6 | -9 | 18 | 26 | -60,877,758 | -36,761,919 | -42,017,051 |
| Income before tax | -6 | -8 | -24,162,279 | -27,048,808 | -61,496,489 | -36,779,400 | -43,766,415 |
| Pretax margin (%) | -152.8 | -420.9 | - | - | - | - | - |
| Provision for income taxes | 0 | - | - | - | - | - | - |
| Effective tax rate (%) | - | - | - | - | - | - | |
| Net income | -6 | -8 | -24,162,279 | -27,048,808 | -61,496,489 | -36,779,400 | -43,766,415 |
| Net income margin (%) | - | - | - | - | - | ||
| Earnings per share | - | - | - | - | - | -0.15 | -3.38 |
| Diluted EPS | - | - | - | - | - | -0.15 | -3.38 |